Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the ...

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the ...

In animal studies, a new diabetes drug has shown positive effects on both blood sugar control and body composition, but ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

Lower blood sugar and increased fat burning - without negatively affecting appetite or muscle mass. These are some of the ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

The once-monthly drug is still under study but could provide added convenience and another option for patients.

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.